Hyper Baric Oxygen Therapy (HBOT) for Spontaneous Osteonecrosis of the Knee

Phase 1UnknownNCT01950858

Assaf-Harofeh Medical Center40 enrolled

Overview

safety and efficacy of Hyper Baric Oxygen (HBO) in patients presenting with spontaneous osteonecrosis of the knee

Study Type

INTERVENTIONAL

Allocation

RANDOMIZED

Purpose

TREATMENT

Masking

NONE

Enrollment

Conditions

Spontaneous Osteonecrosis of the Knee

Interventions

Weight reductionBIOLOGICAL

Eligibility

Sex: ALLMin age: 40 MonthsMax age: 85 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Age40-85 years * Diagnosis of Spontaneous osteonecrosis of the knee (SONK)in last month, Stage 1 or 2 by MRI. Exclusion Criteria: * Hyperbaric treatment (HBOT) in the last 2 years. * Any contraindication for HBOT * Pregnancy. * Inability to sign inform consent * Any contraindication for MRI

Locations (1)

Assaf-Harofeh Medical Center

Ẕerifin, Israel

RECRUITING

Outcomes

Primary Outcomes

Efficacy

Pain Reduction

Time frame: 6 weeks

Safety

Number of Participants with Adverse Events during HBOT

Time frame: end of HBOT

Secondary Outcomes

Reduction In AVN size by MRI

Time frame: 6 weeks

Central Contacts

Yiftah Beer, MD

CONTACT

972-8-9779432 yiftah.beer@gmail.com

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.